Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics-based Lansoprazole Therapy in Children with GERD
NCT00299845Phase 4Withdrawn
- Sponsor
- The University of Osaka
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lansoprazole in gastroesophageal reflux disease (GERD), sponsored by The University of Osaka. Status: withdrawn.
02
Drugs
lansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00299845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299845.